Pheton Holdings ROE 2023-2024 | PTHL
Current and historical return on equity (ROE) values for Pheton Holdings (PTHL) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Pheton Holdings ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.004B | $0.000B |
| Pheton Holdings Ltd, through its wholly owned operating subsidiary, Beijing Feitian Zhaoye Technology Co., Ltd., focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its lead product includes Beijing Feitian's Treatment Planning System. Pheton Holdings Ltd is based in BEIJING, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $159.812B | 29.34 |
| HCA Healthcare (HCA) | United States | $111.062B | 18.39 |
| CVS Health (CVS) | United States | $96.007B | 11.04 |
| Elevance Health (ELV) | United States | $73.505B | 10.78 |
| Cencora (COR) | United States | $65.892B | 21.24 |
| Natera (NTRA) | United States | $33.751B | 0.00 |
| DiDi Global (DIDIY) | China | $24.867B | 20.32 |
| Labcorp Holdings (LH) | United States | $21.421B | 16.33 |
| Medpace Holdings (MEDP) | United States | $15.440B | 38.33 |
| ICON (ICLR) | Ireland | $15.010B | 14.89 |
| BioMerieux (BMXMF) | France | $14.822B | 0.00 |
| Solventum (SOLV) | United States | $14.818B | 14.38 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.851B | 0.00 |
| Viatris (VTRS) | United States | $12.589B | 4.69 |
| CochLear (CHEOY) | Australia | $11.653B | 0.00 |
| Revvity (RVTY) | United States | $11.427B | 21.04 |
| Charles River Laboratories (CRL) | United States | $9.071B | 17.47 |
| Caris Life Sciences,�Inc (CAI) | United States | $8.143B | 0.00 |
| HealthEquity (HQY) | United States | $8.075B | 30.19 |
| Sonic Healthcare (SKHHY) | Australia | $7.567B | 0.00 |
| Avantor (AVTR) | United States | $7.452B | 11.39 |
| BrightSpring Health Services (BTSG) | United States | $6.455B | 38.48 |
| Bausch + Lomb (BLCO) | Canada | $5.958B | 39.12 |
| PACS (PACS) | United States | $4.817B | 29.30 |
| Sotera Health (SHC) | United States | $4.759B | 22.94 |
| GeneDx Holdings (WGS) | United States | $4.595B | 80.69 |
| Alignment Healthcare (ALHC) | United States | $3.912B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.508B | 20.47 |
| Concentras Parent (CON) | United States | $2.495B | 15.58 |
| Surgery Partners (SGRY) | United States | $2.223B | 28.65 |
| Progyny (PGNY) | United States | $2.071B | 40.71 |
| Establishment Labs Holdings (ESTA) | United States | $2.055B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.900B | 11.34 |
| Organon (OGN) | United States | $1.856B | 1.96 |
| Teladoc Health (TDOC) | United States | $1.347B | 0.00 |
| Ardent Health (ARDT) | United States | $1.259B | 4.11 |
| Nutex Health (NUTX) | United States | $1.138B | 8.70 |
| Omada Health (OMDA) | $1.013B | 0.00 | |
| CareDx (CDNA) | United States | $0.953B | 15.57 |
| GoodRx Holdings (GDRX) | United States | $0.920B | 15.06 |
| Embecta (EMBC) | United States | $0.684B | 3.94 |
| InnovAge Holding (INNV) | United States | $0.682B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.578B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.559B | 0.00 |
| Pomdoctor - (POM) | China | $0.552B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.478B | 0.00 |
| Enhabit (EHAB) | United States | $0.472B | 21.20 |
| SBC Medicals (SBC) | United States | $0.385B | 7.08 |
| Strata Critical Medical (SRTA) | United States | $0.376B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.368B | 5.92 |
| QDM (QDMI) | Hong Kong, SAR China | $0.323B | 67.42 |
| So-Young (SY) | China | $0.315B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.313B | 0.00 |
| Oncology Institute (TOI) | United States | $0.298B | 0.00 |
| Agilon Health (AGL) | United States | $0.270B | 0.00 |
| KindlyMD (NAKA) | United States | $0.224B | 0.00 |
| Beauty Health (SKIN) | United States | $0.186B | 0.00 |
| LifeMD (LFMD) | United States | $0.168B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.127B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.119B | 0.00 |
| DocGo (DCGO) | United States | $0.103B | 0.00 |
| Biodesix (BDSX) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.021B | 6.33 |
| Basel Medical Group (BMGL) | Singapore | $0.020B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Lifeward (LFWD) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.005B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |